Added to YB: 2024-05-07
Pitch date: 2024-05-07
MDNA:CN [bullish]
Medicenna Therapeutics Corp.
-69.72%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
Market Cap
CAD 79.2M
Pitch Price
CAD 2.84
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.93
P/E
-5.54
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Medicenna Therapeutics Corp. MDNA:CN
A summary for this pitch has not been created yet.
Read full article (0 min)